Funded Tech Companies
Affinia Therapeutics
Operating out of Waltham, Affinia Therapeutics raised its funding from Lonza Group AG, GV and Farallon Capital Management.
Company Overview
Company Name
Affinia Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
43 Foundry Ave. 120
Waltham, MA 02453
USA
Waltham, MA 02453
USA
Phone
Website
Email Address
Company Background Information
Overview
At Affinia Therapeutics, our purpose is to develop gene therapies that can have a transformative impact on people affected by devastating genetic diseases. Our proprietary platform enables us to methodically engineer novel AAV vectors and gene therapies that have remarkable tissue targeting and other properties.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/4/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Modi
Chief Medical Officer
Petra Kaufmann
Chief Scientific Officer
Charles Albright
Chief Technical Officer
Robert May
Co-Founder
Botond Roska
Co-Founder
Aaron Tward
Co-Founder
Luk Vandenberghe
VP - Bus. Development
Paula Cobb
VP - Bus. Development
Laura Richman
VP - General Counsel
Robert Aboud
Company Investors
- Lonza Group AG
- GV
- Farallon Capital Management
- Avidity Partners
- Octagon Investments Fund
- Atlas Venture (David Grayzel)
- New Enterprise Associates (Ed Mathers)
- TCG Crossover
- EcoR1 Capital Management (Caroline Stout)
- F-Prime Capital (Robert Weisskoff)
- RA Capital
- Casdin Capital
- Perceptive Advisors
- Woodline Partners
- Mass General Brigham Innovation
- Alexandria Venture Investments
- Partners Innovation Fund
Browse more funded tech companies:
Affini-T Therapeutics | Affinimark Technologies
Share this article
About Our VC Transaction Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs